The Future of Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure

The Future of Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure

Cardiac rehabilitation (CR) is a comprehensive program that includes exercise training, titration of medical therapy, lifestyle modification, educational support, and psychosocial assessment. All these components are safe and beneficial resulting in significant improvements in quality of life, funct...

Full description

Bibliographic Details
Main Authors:	Andrea Passantino, Laura Adelaide Dalla Vecchia, Ugo Corrà, Simonetta Scalvini, Massimo Pistono, Maurizio Bussotti, Fabiana Isabella Gambarin, Domenico Scrutinio, Maria Teresa La Rovere
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	heart failure cardiac rehabilitation exercise telerehabilitation cied recipients heart failure with preserved ejection fraction
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.709898/full

Similar Items

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Digoxin and Heart Failure: Are We Clear Yet?
by: Amit Gupta, MD, et al.
Published: (2017-05-01)

Heart failure with preserved ejection fraction – new elements of evidence in the field of pathophysiology and new treatment options
by: Branimir Kanazirev
Published: (2021-07-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Similarities and Differences Between HFmrEF and HFpEF
by: Peixin Li, et al.
Published: (2021-09-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
by: Daniele Masarone, et al.
Published: (2018-11-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report
by: Yuki Asai, et al.
Published: (2021-03-01)

Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
by: Michael Lichtenauer, et al.
Published: (2021-05-01)

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study
by: Bianca Dahlen, et al.
Published: (2021-06-01)

Heart failure with preserved ejection fraction: insights from recent clinical researches
by: Mi-Na Kim, et al.
Published: (2020-05-01)

Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)

Anaemia, iron deficiency and heart failure in 2020: facts and numbers
by: Vijay K. Chopra, et al.
Published: (2020-10-01)

Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
by: E. F. Pavlysh, et al.
Published: (2019-04-01)

Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease
by: Man Liu, et al.
Published: (2020-09-01)

Heart Failure in Patients with Preserved Ejection Fraction: Questions Concerning Clinical Progression
by: George E. Louridas, et al.
Published: (2016-09-01)

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
by: Eduard Shantsila, et al.
Published: (2016-02-01)

Iron Deficiency in Acute Decompensated Heart Failure
by: Anna Beale, et al.
Published: (2019-10-01)

Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
by: Fotini Kalogirou, et al.
Published: (2020-02-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
by: Yook Chin Chia, et al.
Published: (2021-06-01)

Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
by: Vibhu Parcha, et al.
Published: (2021-06-01)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
by: Yi Li, et al.
Published: (2021-06-01)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
by: Dmitry Abramov, et al.
Published: (2021-06-01)

Impact of comorbidities in heart failure – prevalence, effect on functional status, and outcome in indian population: A single-center experience
by: Saurabh Mehrotra, et al.
Published: (2019-01-01)

Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid‐range and preserved ejection fraction
by: Tomoya Ueda, et al.
Published: (2019-10-01)

The tip of the iceberg: finding patients with heart failure with preserved ejection fraction in primary care. An observational study
by: Christi Deaton, et al.
Published: (2018-09-01)

Prognostic role of anemia in heart failure with preserved ejection fraction: A systematic review and meta-analysis
by: Monil Majmundar, et al.
Published: (2021-07-01)

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
by: Ken Watanabe, et al.
Published: (2020-08-01)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
by: Martin Bahls, et al.
Published: (2019-04-01)

Nutrient Intake and Exercise Capacity in Heart Failure With Preserved Ejection Fraction
by: Scott L. Hummel, MD, MS, et al.
Published: (2017-10-01)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
by: Daniela Maria Tanase, et al.
Published: (2019-05-01)

Predictive Role of Diastolic Echocardiographic Findings in the Outcome of Heart Failure with Preserved Ejection Fraction
by: Farveh Vakilian, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_slge36skma51b867v8in16u217